News

Biotech startups find venture capital hard to come by

At a recent meeting of Washington biotech executives and scientists, an entrepreneur addressed the gathering and lamented a local "valley of death" — a reference to the difficulty that scientists have in finding money to take their ideas from the laboratory to the marketplace.

His concern was not new, but it pointed to a hole in the state’s biotech community. Biotech startups, which are heavily capital dependent, need venture capital firms — with their connections and big pocketbooks — to finance research and ultimately get products to market.

By JOSEPH TARTAKOFF
P-I REPORTER

Full Story: http://seattlepi.nwsource.com/business/338066_biotechvc05.html?source=rss

Sorry, we couldn't find any posts. Please try a different search.

Leave a Comment

You must be logged in to post a comment.